CASP3 and thyroid gland carcinoma: Accordingly, we can speculate that thyroid cancers with multiple distant metastases might show higher serum Cyfra 21.1 levels compared with those without distant metastasis, although we were unable to measure caspase 3 activity in metastatic lesions.